TITLE

Bacterial pericarditis and antimicrobial resistance at the Tehran Heart Center, Iran

AUTHOR(S)
Anvari, Maryam Sotoudeh; Kianinejad, Rezvan; Boroumand, Mohammad Ali; Arzhan, Soraya; Jalali, Arash
PUB. DATE
July 2015
SOURCE
Journal of Infection in Developing Countries;Jul2015, Vol. 9 Issue 7, p780
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: When bacterial pericarditis is suspected, urgent pericardial drainage combined with intravenous antibacterial therapy is mandatory to avert devastating, life-threatening complications. There have been scanty results on antimicrobial susceptibility of common causative microorganisms of bacterial pericarditis; most studies had small sample sizes and were performed decades ago. Methodology: This prospective study surveyed the causative bacteria in infectious pericardial effusions and their antimicrobial susceptibility among 320 consecutive cardiac patients who underwent pericardiocentesis at Tehran Heart Center between 2007 and 2012, using the European Society of Cardiology (ESC)'s criteria. Results: Staphylococcus spp. (S. epidermidis, S. aureus, S. haemolyticus) were the main causative organisms isolated from cultures of pericardial effusion samples. Other causative organisms were Streptococcus spp., Enterococcus faecium, Pseudomonas aeruginosa, and Acinetobacter baumannii. In the cultures studied, 35% methicillin-resistant Staphylococcus epidermidis (MRSE) and 42.9% methicillinresistant Staphylococcus aureus (MRSA) were detected. The most effective antimicrobial agents in S. epidermidis were gentamicin, ciprofloxacin, and cefoxitin. Clindamycin was relatively effective. S. aureus was highly susceptible to clindamycin and erythromycin. In cases of S. haemolyticus infection, clindamycin, erythromycin, cefoxitin, and ciprofloxacin were effective antibiotics. Conclusions: In order to diminish the nascence and extension of antimicrobial-resistant pathogens, logical and optimized antimicrobial usage and monitoring in hospitals are highly recommended. It is incumbent on healthcare systems to determine current local resistance patterns by which to guide empiric antimicrobial therapy for specific infections and microorganism types.
ACCESSION #
108715725

 

Related Articles

  • A Phase 2 Trial of Oral Solithromycin 1200 mg or 1000 mg as Single-Dose Oral Therapy for Uncomplicated Gonorrhea. Hook III, Edward W.; Golden, Matthew; Jamieson, Brian D.; Dixon, Paula B.; Harbison, Hanne S.; Lowens, Sylvan; Fernandes, Prabhavathi // Clinical Infectious Diseases;10/1/2015, Vol. 61 Issue 7, p1043 

    Background. Progressive resistance to antimicrobial agents has reduced options for gonorrhea therapy worldwide. Solithromycin (CEM-101) is a novel oral fluoroketolide antimicrobial with substantial in vitro activity against Neisseria gonorrhoeae. Methods. We conducted a phase 2 trial of 2 oral...

  • Reevaluating Fluoroquinolone Breakpoints for Salmonella enterica Serotype Typhi and for Non-Typhi Salmonellae. Crump, John A.; Barrett, Timothy J.; Nelson, Jennifer T.; Angulo, Frederick J. // Clinical Infectious Diseases;7/1/2003, Vol. 37 Issue 1, p75 

    Salmonella enterica infections cause considerable morbidity and mortality worldwide. Antimicrobial therapy may be lifesaving for patients with extraintestinal infections with S. enterica serotype Typhi or non-Typhi salmonellae. Because antimicrobial resistance to several classes of traditional...

  • Drug resistance evolution of Pseudomonas aeruginosa and Acinetobacter baumannii in intensive care units. Nóbrega, Marciano de Sousa; do Carmo Filho, José Rodrigues; Pereira, Milca Severino // Revista Eletronica de Enfermagem;jul-set2013, Vol. 15 Issue 3, p696 

    The objective of this study was to describe the susceptibility of A. baumannii and P. aeruginosa, analyze the trend in bacterial resistance and use of antimicrobial agents. This retrospective, descriptive, cross-sectional study was performed in the adult intensive care units of a large-scale...

  • Clinical significance of infections caused by plasmid-mediated AmpC β-lactamases and extended-spectrum β-lactamase-producing Escherichia coli. Cheong, H.; Ko, K.; Kang, C.-i.; Chung, D.; Peck, K.; Song, J.-h. // Infection;Feb2013, Vol. 41 Issue 1, p287 

    The article discusses the problem of antimicrobial resistance in Escherichia coli (E.coli). It states that extended-spectrum beta-lactamases (ESBLs) mediates the resistance to broad-spectrum antibiotics in E.coli. It also mentions that for reviewing the medical records of individuals diagnosed...

  • Snapshot of Antimicrobial Stewardship in Australian Hospitals. Chen, Alex W. J.; Khumra, Sharmila; Eaton, Vaughn; Kong, David C. M. // Journal of Pharmacy Practice & Research;Mar2010, Vol. 40 Issue 1, p19 

    Background: The diminishing investment into the development of new antimicrobials is of significant global concern. This, coupled with the emergence of anti-infective drug resistance, highlights the need to both prolong and optimise the use of existing antimicrobials. Strategies or programs to...

  • European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries. Amadeo, Brice; Zarb, Peter; Muller, Arno; Drapier, Nico; Vankerckhoven, Vanessa; Rogues, Anne-Marie; Davey, Peter; Goossens, Herman // Journal of Antimicrobial Chemotherapy (JAC);Oct2010, Vol. 65 Issue 10, p2247 

    Background: Antimicrobials are the most common medicines prescribed to children, but very little is known about patterns of hospital paediatric antimicrobial prescribing. This study aimed at describing paediatric antimicrobial prescribing in European hospitals to identify targets for quality...

  • Failing to tackle drug-resistant superbugs will cost up to $100 trillion.  // Healthcare Purchasing News;Jan2015, Vol. 39 Issue 1, p18 

    The article discusses the Review on Antimicrobial Resistance study conducted by economist Jim O'Neill for British Prime Minister David Cameron to assess the global mortality and morbidity impact of superbug infection.

  • Possible Role of Curcumin as an Efflux Pump Inhibitor in Multi Drug Resistant Clinical Isolates of Pseudomonas aeruginosa. NEGI, NIDHI; PRAKASH, PRADYOT; GUPTA, MOHAN LAL; MOHAPATRA, TRIBHUBAN MOHAN // Journal of Clinical & Diagnostic Research;Oct2014, Vol. 8 Issue 10, p4 

    Introduction: Multidrug resistant non-fermenters are continuously increasing in hospital and ICU settings. One of the mechanisms of developing drug resistance is possession of efflux pump through which bacteria extrude antimicrobial agents and other toxic substances. If these efflux channels are...

  • High Mortality from Blood Stream Infection in Addis Ababa, Ethiopia, Is Due to Antimicrobial Resistance. Seboxa, Teshale; Amogne, Wondwossen; Abebe, Workeabeba; Tsegaye, Tewodros; Azazh, Aklilu; Hailu, Workagegnehu; Fufa, Kebede; Grude, Nils; Henriksen, Thor-Henrik // PLoS ONE;12/15/2015, Vol. 10 Issue 12, p1 

    Background: Managing blood stream infection in Africa is hampered by lack of bacteriological support needed for antimicrobial stewardship, and background data needed for empirical treatment. A combined pro- and retrospective approach was used to overcome thresholds in clinical research in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics